Sharon, MA, United States of America

Zhao Chen

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Dana-Farber-Cancer Institute Inc.. Active years: 2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Zhao Chen. Retrieved from https://idiyas.com/inventor/zhao-chen-ziqi0tct

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations in Cancer Treatment by Zhao Chen

Introduction

Zhao Chen is a notable inventor based in Sharon, MA, who has made significant contributions to the field of cancer treatment. His innovative approach focuses on utilizing combination therapies to enhance the effectiveness of existing treatments.

Latest Patents

Zhao Chen holds a patent for a groundbreaking invention titled "Combination therapy for cancer using bromodomain and extra-terminal (BET) protein inhibitors." This patent outlines methods for treating cancer by combining BET protein inhibitors with specific chemotherapeutic drugs, aiming to improve patient outcomes.

Career Highlights

Zhao Chen is affiliated with the Dana-Farber Cancer Institute Inc., where he applies his expertise in cancer research and treatment. His work is pivotal in advancing therapeutic strategies that target cancer more effectively.

Collaborations

Zhao has collaborated with esteemed colleagues such as James Elliott Bradner and Michael Robert McKeown, contributing to a rich environment of innovation and research in cancer therapies.

Conclusion

Zhao Chen's contributions to cancer treatment through his patented methods exemplify the potential of innovative therapies in improving patient care. His work continues to inspire advancements in the medical field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…